Conron M - Search Results

1

Prospects for the development of small molecular weight compounds to replace anti-tumour necrosis factor biological agents.

Foxwell B, Andreakos E, Brennan F, Feldmann M, Smith C, Conron M. Foxwell B, et al. Among authors: conron m. Ann Rheum Dis. 2003 Nov;62 Suppl 2(Suppl 2):ii90-3. doi: 10.1136/ard.62.suppl_2.ii90. Ann Rheum Dis. 2003. PMID: 14532159 Free PMC article. Review. No abstract available.

2

Alveolar macrophages and T cells from sarcoid, but not normal lung, are permissive to adenovirus infection and allow analysis of NF-kappa b-dependent signaling pathways.

Conron M, Bondeson J, Pantelidis P, Beynon HL, Feldmann M, duBois RM, Foxwell BM. Conron M, et al. Am J Respir Cell Mol Biol. 2001 Aug;25(2):141-9. doi: 10.1165/ajrcmb.25.2.4327. Am J Respir Cell Mol Biol. 2001. PMID: 11509322

3

Nuclear factor-kappaB activation in alveolar macrophages requires IkappaB kinase-beta, but not nuclear factor-kappaB inducing kinase.

Conron M, Andreakos E, Pantelidis P, Smith C, Beynon HL, Dubois RM, Foxwell BM. Conron M, et al. Am J Respir Crit Care Med. 2002 Apr 1;165(7):996-1004. doi: 10.1164/ajrccm.165.7.2107058. Am J Respir Crit Care Med. 2002. PMID: 11934728

4

Churg-Strauss syndrome.

Conron M, Beynon HL. Conron M, et al. Thorax. 2000 Oct;55(10):870-7. doi: 10.1136/thorax.55.10.870. Thorax. 2000. PMID: 10992542 Free PMC article. Review. No abstract available.

5

Ketoconazole for the treatment of refractory hypercalcemic sarcoidosis.

Conron M, Beynon HL. Conron M, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2000 Oct;17(3):277-80. Sarcoidosis Vasc Diffuse Lung Dis. 2000. PMID: 11033844

6

Immunological mechanisms in sarcoidosis.

Conron M, Du Bois RM. Conron M, et al. Clin Exp Allergy. 2001 Apr;31(4):543-54. doi: 10.1046/j.1365-2222.2001.01116.x. Clin Exp Allergy. 2001. PMID: 11359421 Review. No abstract available.

7

Sarcoidosis.

Hart LA, Conron M, du Bois RM. Hart LA, et al. Among authors: conron m. Int J Tuberc Lung Dis. 2001 Sep;5(9):791-806. Int J Tuberc Lung Dis. 2001. PMID: 11573890 Review.

8

Calcium metabolism in sarcoidosis and its clinical implications.

Conron M, Young C, Beynon HL. Conron M, et al. Rheumatology (Oxford). 2000 Jul;39(7):707-13. doi: 10.1093/rheumatology/39.7.707. Rheumatology (Oxford). 2000. PMID: 10908687

9

Churg-Strauss syndrome presenting with visual loss.

Carmichael J, Conron M, Beynon H, Crow J, Warner TT. Carmichael J, et al. Among authors: conron m. Rheumatology (Oxford). 2000 Dec;39(12):1433-4. doi: 10.1093/rheumatology/39.12.1433. Rheumatology (Oxford). 2000. PMID: 11136895 No abstract available.

10

Small changes in six-minute walk distance are important in diffuse parenchymal lung disease.

Holland AE, Hill CJ, Conron M, Munro P, McDonald CF. Holland AE, et al. Among authors: conron m. Respir Med. 2009 Oct;103(10):1430-5. doi: 10.1016/j.rmed.2009.04.024. Epub 2009 May 23. Respir Med. 2009. PMID: 19477109 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters